Compare Stocks → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison CVE:LXENASDAQ:PHARCVE:RTNCVE:SNM Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeLXELeucrotta ExplorationC$2.21C$2.21C$0.64▼C$2.24C$551.95MN/A548,019 shs310,100 shsPHARPharming Group$9.60-3.2%$10.96$9.27▼$16.71$644.26M0.162,596 shs794 shsRTNReturn EnergyC$0.04+40.0%C$0.03C$0.02▼C$0.04C$914KN/A11.77 million shs13.47 million shsSNMShaMaran PetroleumC$0.08-11.8%C$0.06C$0.04▼C$0.09C$211.50M1.13335,116 shs24,739 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceLXELeucrotta Exploration0.00%0.00%0.00%0.00%0.00%PHARPharming Group-0.80%-2.84%-11.98%-17.33%-7.29%RTNReturn Energy0.00%0.00%0.00%0.00%0.00%SNMShaMaran Petroleum+13.33%+21.43%+41.67%+88.89%+13.33%top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution…MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationLXELeucrotta ExplorationN/AN/AN/AN/AN/AN/AN/AN/APHARPharming Group2.4797 of 5 stars3.55.00.00.02.60.00.6RTNReturn EnergyN/AN/AN/AN/AN/AN/AN/AN/ASNMShaMaran PetroleumN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceLXELeucrotta ExplorationN/AN/AN/AN/APHARPharming Group3.00Buy$37.00285.42% UpsideRTNReturn EnergyN/AN/AN/AN/ASNMShaMaran PetroleumN/AN/AN/AN/ACurrent Analyst RatingsLatest SAVP, SNM, LXE, RTN, and PHAR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/14/2024PHARPharming GroupHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$37.00(Data available from 4/23/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookLXELeucrotta ExplorationC$44.13M12.51C$0.13 per share17.68C$1.30 per share1.70PHARPharming Group$245.32M2.63$0.09 per share102.60$3.26 per share2.94RTNReturn EnergyC$1.54M0.59C$0.01 per share3.33C$0.01 per share4.38SNMShaMaran PetroleumC$82.89M2.55C$0.02 per share3.96C$0.05 per share1.50Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateLXELeucrotta ExplorationN/AC$0.405.54∞0.11N/AN/AN/AN/APHARPharming Group-$10.55M-$0.14N/AN/AN/A-4.13%-4.53%-2.14%5/9/2024 (Estimated)RTNReturn EnergyN/A-C$0.01N/A∞N/AN/AN/AN/AN/ASNMShaMaran Petroleum-C$26.71M-C$0.01N/A∞N/A-32.22%-17.62%0.87%5/8/2024 (Estimated)Latest SAVP, SNM, LXE, RTN, and PHAR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/14/2024Q4 2023PHARPharming Group$0.05-$0.03-$0.08-$0.02$71.83 million$81.20 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthLXELeucrotta ExplorationN/AN/AN/AN/AN/APHARPharming GroupN/AN/AN/AN/AN/ARTNReturn EnergyC$3.479,914.29%N/AN/A N/ASNMShaMaran PetroleumN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioLXELeucrotta Exploration0.164.554.34PHARPharming Group0.624.063.33RTNReturn Energy168.129.439.36SNMShaMaran Petroleum183.221.571.07OwnershipInstitutional OwnershipCompanyInstitutional OwnershipLXELeucrotta ExplorationN/APHARPharming Group0.03%RTNReturn EnergyN/ASNMShaMaran Petroleum2.50%Insider OwnershipCompanyInsider OwnershipLXELeucrotta ExplorationN/APHARPharming Group2.07%RTNReturn EnergyN/ASNMShaMaran Petroleum26.20%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableLXELeucrotta Exploration16249.75 millionN/ANot OptionablePHARPharming Group33267.11 million65.72 millionNot OptionableRTNReturn EnergyN/A26.11 millionN/ANot OptionableSNMShaMaran Petroleum92.82 billionN/ANot OptionableSAVP, SNM, LXE, RTN, and PHAR HeadlinesSourceHeadlineAlex C. Lengyel Sells 356,160 Shares of ShaMaran Petroleum Corp. (CVE:SNM) Stockinsidertrades.com - April 23 at 4:22 AMShaMaran Petroleum (CVE:SNM) shareholder returns have been decent, earning 40% in 3 yearsuk.finance.yahoo.com - March 21 at 10:54 AMShaMaran Corporate Updatefinance.yahoo.com - March 13 at 7:06 PMShaMaran Reports Year-End 2023 Reserves and Resourcesfinance.yahoo.com - February 14 at 5:50 PMClosing Bell: Shamaran Petroleum Corp flat on Tuesday (SNM)theglobeandmail.com - January 6 at 3:16 PMShaMaran Petroleum Corp (SHASF)uk.finance.yahoo.com - November 13 at 9:31 AMShaMaran Petroleum Corp (SNM.ST)uk.finance.yahoo.com - November 13 at 9:31 AMShaMaran Petroleum: Top 10 Undervalued Oil & Gas Industry Stocks (SNM)theglobeandmail.com - November 11 at 10:47 AMShaMaran Reports Third Quarter 2023 Resultsfinance.yahoo.com - November 8 at 6:26 PMShaMaran Petroleum: Top 10 Undervalued Energy Sector Stocks on TSX-V (SNM)theglobeandmail.com - November 1 at 3:29 PMThe past five years for ShaMaran Petroleum (CVE:SNM) investors has not been profitablefinance.yahoo.com - October 13 at 8:19 AMClosing Bell: Shamaran Petroleum Corp up on Wednesday (SNM)theglobeandmail.com - October 5 at 6:38 PMShaMaran Petroleum reports Q2 resultsmsn.com - August 10 at 6:57 PMShaMaran Reports Second Quarter 2023 Resultsca.finance.yahoo.com - August 9 at 8:15 PMShaMaran Operational and Corporate Updatefinance.yahoo.com - July 12 at 1:25 AMShaMaran Petroleum Corp. (CVE:SNM) Screens Well But There Might Be A Catchfinance.yahoo.com - June 28 at 10:30 AMShaMaran Announces Annual Meeting Voting Resultsfinance.yahoo.com - June 22 at 6:56 PMShould You Be Adding ShaMaran Petroleum (CVE:SNM) To Your Watchlist Today?finance.yahoo.com - June 1 at 8:48 AMShaMaran Appoints Garrett Soden as President and CEOfinance.yahoo.com - May 15 at 3:07 PMShaMaran Petroleum net result of $9.6M, revenue of $43.38Mmsn.com - May 11 at 7:20 PMSHAMARAN REPORTS STRONG FIRST QUARTER RESULTSbenzinga.com - May 10 at 11:19 PMClosing Bell: Shamaran Petroleum Corp down on Wednesday (SNM)theglobeandmail.com - May 4 at 9:48 AMClosing Bell: Shamaran Petroleum Corp down on Tuesday (SNM)theglobeandmail.com - May 3 at 9:09 AMExplosion at Seneca Petroleum Lemont: One person killed in horror chemical plant blastmirror.co.uk - May 1 at 1:07 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop Headlines3 Value Stocks Too Small For Buffett’s PortfolioMarch 28, 2024 12:16 PMView 3 Value Stocks Too Small For Buffett’s Portfolio3 High Dividend Stocks to Replace Lower Savings Yields AheadApril 9, 2024 9:15 AMView 3 High Dividend Stocks to Replace Lower Savings Yields AheadCan Altimmune get its GLP-1 Drug to Market Before Cash Rush Out? April 9, 2024 6:07 AMView Can Altimmune get its GLP-1 Drug to Market Before Cash Rush Out? Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?March 28, 2024 8:43 AMView Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?Krispy Kreme’s Hangover from McDonald’s Deal Bestows Pullback OppApril 8, 2024 6:10 AMView Krispy Kreme’s Hangover from McDonald’s Deal Bestows Pullback OppAll Headlines Company DescriptionsLeucrotta ExplorationCVE:LXELeucrotta Exploration Inc., an oil and natural gas company, acquires, explores for, develops, and produces oil and natural gas reserves in northeastern British Columbia, Canada. As of December 31, 2021, it owned approximately 213,000 net acres of land. The company was incorporated in 2014 and is based in Calgary, Canada.Pharming GroupNASDAQ:PHARPharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's commercialized product is RUCONEST, a plasma-free rhC1INH protein replacement therapy for the treatment acute hereditary angioedema (HAE) attacks. It also engages in the development of leniolisib for the treatment of activated phosphoinositide 3-kinase delta syndrome; OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE; and alpha-glucosidase therapy for the treatment of Pompe and fabry diseases. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. is headquartered in Leiden, the Netherlands.Return EnergyCVE:RTNReturn Energy Inc. engages in the exploration for, development, and production of petroleum and natural gas properties in the Western Canadian Sedimentary Basin. The company holds interests in the producing oil and gas assets in the Peace River Arch Area of Northwest Alberta. It primarily owns and operates a 100% interest in the Rycroft gas plant and associated gathering system. The company was formerly known as DualEx Energy International Inc. and changed its name to Return Energy Inc. in December 2016. Return Energy Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.ShaMaran PetroleumCVE:SNMShaMaran Petroleum Corp., together with its subsidiaries, engages in the oil and gas exploration and production. It holds interest in the Atrush Block production sharing contract; and in the Sarsang Production Sharing Contract in the Kurdistan region of Iraq. The company was incorporated in 1991 and is headquartered in Vancouver, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.